Financial News

Recent Quotes

My Watchlist

Indicators

Overview

Week In Review: Sanofi Acquires Kadmon, A US-China Pharma, For $1.9 Billion

By: TalkMarkets

September 11, 2021 at 14:30 PM EDT

France's Sanofi will acquire Kadmon Holdings of New York City in a $1.9 billion deal. In 2019, Kadmon formed a JV with BioNova Pharma to develop its novel lead drug, Rezurock (belumosudil) in China.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Financial News

Week In Review: Sanofi Acquires Kadmon, A US-China Pharma, For $1.9 Billion

Popular Pages